Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;30(8):342-8.
doi: 10.1089/cbr.2015.1862. Epub 2015 Sep 18.

Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter

Affiliations

Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter

Ling Li et al. Cancer Biother Radiopharm. 2015 Oct.

Abstract

Aim: To investigate the enhancing effect of radionuclide therapy by the therapeutic gene placed under the control of radio-responsive promoter.

Methods: The recombinant lentivirus E8-codA-GFP, including a synthetic radiation-sensitive promoter E8, cytosine deaminase (CD) gene, and green fluorescent protein gene, was constructed. The gene expression activated by (125)I radiation was assessed by observation of green fluorescence. The ability of converting 5-fluorocytosine (5-FC) to 5-fluorourial (5-FU) by CD enzyme was assessed by high-performance liquid chromatography. The viability of the infected cells exposed to (125)I in the presence of 5-FC was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and the infected cells exposed to (125)I alone served as negative control and 5-FU as positive control.

Results: The recombinant lentiviral vector was constructed successfully. On exposure of infected cells to (125)I, green fluorescence can be observed and 5-FU can be detected. MTT assay showed that the survival rate for infected cells treated with (125)I was lower compared with the (125)I control group, but higher than the positive control group.

Conclusion: The synthetic promoter E8 can induce the expression of downstream CD gene under (125)I radiation, and the tumor killing effect of (125)I can be enhanced by combining CD gene therapy with radiosensitive promoter.

Keywords: 125I; 5-fluorocytosine; cytosine deaminase; radiation-sensitive promoter; recombinant lentivirus.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Gel electrophoresis of cytosine deaminase (CD) gene in pGC-FU-E8-codA-GFP plasmid. The right lane: DNA marker, the left lane: CD gene (1327 bp).
<b>FIG. 2.</b>
FIG. 2.
Gel electrophoresis of E8 promoter in pGC-FU-E8-codA-GFP plasmid. The right lane: molecular marker, the left lane: E8 gene (96 bp).
<b>FIG. 3.</b>
FIG. 3.
Infected EJ cells green fluorescence expressions induced by different doses of 125I GFP-positive cells were seen in dark green. Group (a–e) performed cells induced by 0, 18.5, 37.0, 55.5, and 74.0 kBq 125I. The expression of fluorescence can be seen at the dose as low as 18.5 kBq and was clearer with the increased dose of 125I.

Similar articles

Cited by

References

    1. Yoshida C, Tsuji AB, Sudo H, et al. . Therapeutic efficacy of c-kit-targeted radioimmunotherapy using 90Y-labeled anti-c-kit antibodies in a mouse model of small cell lung cancer. PLoS One 2013;8:e59248. - PMC - PubMed
    1. Walter RB, Press OW, Pagel JM. Pretargeted radioimmunotherapy for hematologic and other malignancies. Cancer Biother Radiopharm 2010;25:125. - PMC - PubMed
    1. Pool SE, Krenning EP, Koning GA, et al. . Preclinical and clinical studies of peptide receptor radionuclide therapy. Semin Nucl Med 2010;40:209. - PubMed
    1. Gupta SK, Singla S, Bal C. Renal and hematological toxicity in patients of neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-DOTATATE. Cancer Biother Radiopharm 2012;27:593. - PubMed
    1. Inoue S, Patil R, Portilla-Arias J, et al. . Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PLoS One 2012;7:e31070. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources